Week in Review: November 4–8

Infant immune systems suppressed; why tissues are tough to freeze; silencing one gene causes secondary effects; estrogen’s role in drug-resistant breast cancer

Written byTracy Vence
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, ERNEST FNewborns have infamously weak immune systems, which make them susceptible to various infections. According to a new mouse study, though, having a dampened immune response can be a good thing—it helps let beneficial bacteria colonize. Researchers from Cincinnati Children’s Hospital Medical Center showed in Nature this week that CD71+ cells actively suppress immune responses in newborn mice.

“This more intricate regulation of immune responses makes more sense than immaturity, because it allows a protective response to be mounted if needed,” study coauthor Sing Sing Way told The Scientist.

ADAM HIGGINS AND JENS KARLSSONCompared with single cells, tissue samples are notoriously difficult to freeze. Researchers from Villanova University in Pennsylvania and the University of Oregon this week showed that tight junctions between cells are to blame for intracellular ice formation (IIF), which can severely damage frozen tissues.

John Bischof, a professor of mechanical engineering at the University of Minnesota, who was not involved in the work, told The Scientist that this finding “has important implications in explaining ice formation and the ensuing injury in tissues, a poorly understood phenomenon in cryobiology and regenerative medicine research.”

FLICKR, ZEISS MICROSCOPYInvestigators from Johns Hopkins University School of Medicine in Baltimore, Maryland, have found that silencing a single gene can cause profound secondary mutations in the yeast genome. Their observations were published in Molecular Cell this week.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies